Your browser doesn't support javascript.
loading
Cyclic AMP (cAMP) confers drug resistance against DNA damaging agents via PKAIA in CML cells.
Xiao, Ling-Yi; Kan, Wai-Ming.
Affiliation
  • Xiao LY; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan.
  • Kan WM; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 701, Taiwan. Electronic address: Vincent@mail.ncku.edu.tw.
Eur J Pharmacol ; 794: 201-208, 2017 Jan 05.
Article in En | MEDLINE | ID: mdl-27894809
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Cyclic AMP / Drug Resistance, Neoplasm / Cyclic AMP-Dependent Protein Kinase Type I Limits: Humans Language: En Journal: Eur J Pharmacol Year: 2017 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: DNA Damage / Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Cyclic AMP / Drug Resistance, Neoplasm / Cyclic AMP-Dependent Protein Kinase Type I Limits: Humans Language: En Journal: Eur J Pharmacol Year: 2017 Document type: Article Affiliation country: